Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
121.4 SAR | -0.65% | -8.45% | +8.59% |
May. 14 | Tadawul All Share Index Down; Saudi's Biggest IPO of the Year Prices | MT |
May. 14 | Mouwasat Medical Services Sees Profit, Revenue Growth in Q1 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company is in a robust financial situation considering its net cash and margin position.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.49 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.59% | 6.52B | D | ||
-18.84% | 16.76B | B+ | ||
+3.60% | 12.65B | B | ||
+3.98% | 11.86B | B+ | ||
+4.28% | 10.28B | B+ | ||
+28.57% | 8.67B | B | ||
-6.94% | 7.6B | A- | ||
+6.29% | 6.8B | B- | ||
+39.21% | 4.53B | - | ||
-3.49% | 4.39B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4002 Stock
- Ratings Mouwasat Medical Services Company